Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention

References

• JurenkaJSTherapeutic applications of pomegranate (Punica granatum L.): a reviewAltern Med Rev200813212814418590349
   PubMedGoogle Scholar
• JohanningsmeierSDHarrisGKPomegranate as a functional food and nutraceutical sourceAnnu Rev Food Sci Technol2011218120122129380
   PubMed Web of Science ®Google Scholar
• HeberDPomegranates: Ancient Roots to Modern MedicineBoca Raton, FLCRC Press2006
   Google Scholar
• HeberDPomegranate ellagitanninsBenzieIFFWachtel-GalorSHerbal Medicine: Biomolecular and Clinical AspectsBoca Raton, FLCRC Press2011
   Google Scholar
• GilMITomas-BarberanFAHess-PierceBHolcroftDMKaderAAAntioxidant activity of pomegranate juice and its relationship with phenolic composition and processingJ Agric Food Chem200048104581458911052704
   PubMed Web of Science ®Google Scholar
• CerdaBLlorachRCeronJJEspinJCTomas-BarberanFAEvaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juiceEur J Nutr2003421182812594538
   PubMed Web of Science ®Google Scholar
• SeeramNLeeRHardyMHeberDRapid large scale purification of ellagitannins from pomegranate husk, a by-product of the commercial juice industrySep Purif Technol20054114955
   Web of Science ®Google Scholar
• LarrosaMGarcia-ConesaMTEspinJCTomas-BarberanFAEllagitannins, ellagic acid and vascular healthMol Aspects Med201031651353920837052
   PubMed Web of Science ®Google Scholar
• SyedDNAfaqFMukhtarHPomegranate derived products for cancer chemopreventionSemin Cancer Biol200717537738517613245
   PubMedGoogle Scholar
• KasimsettySGBialonskaDReddyMKMaGKhanSIFerreiraDColon cancer chemopreventive activities of pomegranate ellagitannins and urolithinsJ Agric Food Chem20105842180218720112993
   PubMed Web of Science ®Google Scholar
• WangLAlconAYuanHHoJLiQJMartins-GreenMCellular and molecular mechanisms of pomegranate juice-induced antimetastatic effect on prostate cancer cellsIntegr Biol (Camb)20113774275421594291
   PubMedGoogle Scholar
• AdhamiVMKhanNMukhtarHCancer chemoprevention by pomegranate: laboratory and clinical evidenceNutr Cancer200961681181520155621
   PubMed Web of Science ®Google Scholar
• ShirodeABKovvuruPChitturSVHenningSMHeberDRelieneRAntiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaksMol Carcinog201453645847023359482
   PubMed Web of Science ®Google Scholar
• AdamsLSSeeramNPAggarwalBBTakadaYSandDHeberDPomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cellsJ Agric Food Chem200654398098516448212
   PubMed Web of Science ®Google Scholar
• AfaqFSaleemMKruegerCGReedJDMukhtarHAnthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 miceInt J Cancer2005113342343315455341
   PubMed Web of Science ®Google Scholar
• AlbrechtMJiangWKumi-DiakaJPomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cellsJ Med Food20047327428315383219
   PubMed Web of Science ®Google Scholar
• KhanNHadiNAfaqFSyedDNKweonMHMukhtarHPomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude miceCarcinogenesis200728116317316920736
   PubMed Web of Science ®Google Scholar
• AdhamiVMSiddiquiIASyedDNLallRKMukhtarHOral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP modelCarcinogenesis201233364465122198212
   PubMedGoogle Scholar
• PantuckAJLeppertJTZomorodianNPhase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancerClin Cancer Res200612134018402616818701
   PubMed Web of Science ®Google Scholar
• PallerCJYeXWozniakPJA randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancerProstate Cancer Prostatic Dis2013161505522689129
   PubMedGoogle Scholar
• AqilFMunagalaRVadhanamMVAnti-proliferative activity and protection against oxidative DNA damage by punicalagin isolated from pomegranate huskFood Res Int201249134535323493479
   PubMedGoogle Scholar
• KhandujaKLGandhiRKPathaniaVSyalNPrevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in miceFood Chem Toxicol199937431331810418948
   PubMedGoogle Scholar
• BerniAGrossiMRPepeGProtective effect of ellagic acid (EA) on micronucleus formation induced by N-methyl-N’-nitro-N-nitrosoguanidine (MNNG) in mammalian cells, in in vitro assays and in vivoMutat Res20127461606522475933
   PubMedGoogle Scholar
• AnithaPPriyadarsiniRVKavithaKThiyagarajanPNaginiSEllagic acid coordinately attenuates Wnt/beta-catenin and NF-kappaB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesisEur J Nutr2013521758422160170
   PubMedGoogle Scholar
• AiyerHSSrinivasanCGuptaRCDietary berries and ellagic acid diminish estrogen-mediated mammary tumorigenesis in ACI ratsNutr Cancer200860222723418444155
   PubMed Web of Science ®Google Scholar
• EdderkaouiMOdinokovaIOhnoIEllagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cellsWorld J Gastroenterol200814233672368018595134
   PubMed Web of Science ®Google Scholar
• HoCCHuangACYuCSEllagic acid induces apoptosis in tsgh8301 human bladder cancer cells through the endoplasmic reticulum stress- and mitochondria-dependent signaling pathwaysEnviron Toxicol201429111262127423554011
   PubMedGoogle Scholar
• PitchakarnPChewonarinTOgawaKEllagic acid inhibits migration and invasion by prostate cancer cell linesAsian Pac J Cancer Prev20131452859286323803044
   PubMedGoogle Scholar
• QiuZZhouBJinLIn vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cellsFood Chem Toxicol20135942843723811531
   PubMed Web of Science ®Google Scholar
• SeeramNPHenningSMZhangYSuchardMLiZHeberDPomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hoursJ Nutr2006136102481248516988113
   PubMed Web of Science ®Google Scholar
• CerdaBTomas-BarberanFAEspinJCMetabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variabilityJ Agric Food Chem200553222723515656654
   PubMed Web of Science ®Google Scholar
• CerdaBEspinJCParraSMartinezPTomas-BarberanFAThe potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humansEur J Nutr200443420522015309440
   PubMed Web of Science ®Google Scholar
• SmartRCHuangMTChangRLSayerJMJerinaDMConneyAHDisposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3,3′-di-O-methylellagic acid in miceCarcinogenesis1986710166316673093111
   PubMedGoogle Scholar
• WhitleyACStonerGDDarbyMVWalleTIntestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid – extensive binding to protein and DNABiochem Pharmacol200366690791512963477
   PubMedGoogle Scholar
• SeeramNPLeeRHeberDBioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juiceClin Chim Acta20043481–2636815369737
   PubMed Web of Science ®Google Scholar
• BharaliDJMousaSAEmerging nanomedicines for early cancer detection and improved treatment: current perspective and future promisePharmacol Ther2010128232433520705093
   PubMed Web of Science ®Google Scholar
• SiddiquiIAAdhamiVMBharaliDJIntroducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallateCancer Res20096951712171619223530
   PubMed Web of Science ®Google Scholar
• BharaliDJSiddiquiIAAdhamiVMNanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospectsCancers2011201134024404524213123
   PubMedGoogle Scholar
• SannaVSiddiquiIASechiMMukhtarHNanoformulation of natural products for prevention and therapy of prostate cancerCancer Lett2013334114215123201598
   PubMedGoogle Scholar
• SrivastavaAKBhatnagarPSinghMSynthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damageInt J Nanomedicine201381451146223717041
   PubMed Web of Science ®Google Scholar
• XieXTaoQZouYPLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanismsJ Agric Food Chem201159179280928921797282
   PubMed Web of Science ®Google Scholar
• SannaVSiddiquiIASechiMMukhtarHResveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatmentMol Pharm201310103871388123968375
   PubMedGoogle Scholar
• LüJMWangXMarin-MullerCCurrent advances in research and clinical applications of PLGA-based nanotechnologyExpert Rev Mol Diagn20099432534119435455
   PubMed Web of Science ®Google Scholar
• DanhierFAnsorenaESilvaJMCocoRLe BretonAPreatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552222353619
   PubMed Web of Science ®Google Scholar
• SahHThomaLADesuHRSahEWoodGCConcepts and practices used to develop functional PLGA-based nanoparticulate systemsInt J Nanomed20138747765
   PubMed Web of Science ®Google Scholar
• KalariaDRSharmaGBeniwalVRavi KumarMNDesign of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in ratsPharm Res200926349250118998202
   PubMed Web of Science ®Google Scholar
• KumarGSharmaSShafiqNPandhiPKhullerGKMalhotraSPharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosisDrug Deliv2011181657320735202
   PubMed Web of Science ®Google Scholar
• HeWHornSWHussainMDImproved bioavailability of orally administered mifepristone from PLGA nanoparticlesInt J Pharm20073341–217317817101249
   PubMedGoogle Scholar
• YangTTSinaiPKainSRAn acid phosphatase assay for quantifying the growth of adherent and nonadherent cellsAnal Biochem199624111031088921171
   PubMedGoogle Scholar
• CerdaBCeronJJTomas-BarberanFAEspinJCRepeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxicJ Agric Food Chem200351113493350112744688
   PubMed Web of Science ®Google Scholar
• AqilFVadhanamMVGuptaRCEnhanced activity of punicalagin delivered via polymeric implants against benzo[a]pyrene-induced DNA adductsMutat Res20127431–2596622234049
   PubMed Web of Science ®Google Scholar
• LarrosaMTomas-BarberanFAEspinJCThe dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathwayJ Nutr Biochem200617961162516426830
   PubMed Web of Science ®Google Scholar
• LiZPercivalSSBonardSGuLFabrication of nanoparticles using partially purified pomegranate ellagitannins and gelatin and their apoptotic effectsMol Nutr Food Res20115571096110321374799
   PubMed Web of Science ®Google Scholar
• BharaliDJYalcinMDavisPJMousaSATetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancerNanomedicine (Lond)20138121943195423448245
   PubMed Web of Science ®Google Scholar
• KhalilNMdo NascimentoTCCasaDMPharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in ratsColloids Surf B Biointerfaces201310135336023010041
   PubMed Web of Science ®Google Scholar